# Christopher M. Booth

Source: https://onco.cc/people/christopher-booth/  
OnCo record `christopher-booth` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Oncologist who co-led CHALLENGE and founded Common Sense Oncology to refocus trials on outcomes that matter to patients.

## Summary

Christopher Booth (Queen's University, Canada) was co-principal investigator of the CHALLENGE trial showing exercise improves survival after colon cancer, and founded Common Sense Oncology, an international movement arguing that trials should measure overall survival and quality of life, avoid weak surrogate endpoints and address affordability. His health services research examines the real-world value of new cancer drugs.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: evidence; policy; exercise
- Role: Professor of Oncology and Public Health Sciences, Queen's University; Medical Oncologist, Kingston Health Sciences Centre
- Specialisms: Cancer policy and evidence; Common Sense Oncology; Health services research; Exercise oncology

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Booth%20CM%5BAuthor%5D%20oncology

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- technologies: [Exercise & lifestyle oncology](https://onco.cc/technologies/exercise-oncology/)
- institutions: [Queen's University / Kingston Health Sciences Centre](https://onco.cc/institutions/queens-university-kingston/)
- trials: [CHALLENGE (CCTG CO.21)](https://onco.cc/trials/challenge/)
- key papers: [CHALLENGE: a structured exercise programme after chemotherapy improves survival in colon cancer](https://onco.cc/key-papers/paper-challenge-exercise-nejm-2025/), [Prasad: most surrogate endpoints in cancer trials correlate poorly with survival](https://onco.cc/key-papers/paper-prasad-surrogate-endpoints-jama-im-2015/)

---
JSON: https://onco.cc/api/v1/entities/christopher-booth.json